drugset / Trial / NCT04538976

Copd Exacerbation and Pulmonary Hypertension Trial

NCT04538976

RandomizedParallel-groupOpen-labelTreatment

Summary

This trial will investigate whether patiens admitted with an acute exacerbation of chronic obstructive lung disease and pulmonary hypertension will benefit from a targeted pharmacological treatment.

Timeline

Start
2020-02-01
Primary completion
2024-03-15
Completion
2024-03-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown

Indications

No indication recorded.